CEO Inventor of the Rivelin® technology and co-founder of Dermtreat ApS. Previously VP R&D, Dumex-Alpharma, adjunct professor in physical-chemistry – Copenhagen University, VP Pharmaceutical Research and Development and cVP New Products, LEO Pharma. Has brought 7 products to market in USA, Europe and Japan.
Private investor having developed and worked with a number of SMEs – including funding, operations and exit. Previously experienced from large listed companies (AP Moller, FLSmidth and IC Companys), including positions as Group Treasurer and CFO.